Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

EMA Guideline Seeks To Revive Drug Development For Alzheimer's Disease

This article was originally published in SRA

Executive Summary

The European Medicines Agency is seeking feedback on a revised guideline on developing drugs for treating Alzheimer’s disease, a condition for which the agency has warned there is a lack of medicines innovation.